Equity Capital Markets

Company · CIK 1754068

Kalaris Therapeutics, Inc.

CIK1754068 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressNJ
ListedKLRS (Nasdaq)
First annual or quarterly report2020-09-02

Offerings

5 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-294881
ShelfEffective
 2026-04-032026-04-132
333-294883
ShelfEffective
 2026-04-032026-04-132
333-269808
ShelfWithdrawn
 2023-02-152024-02-152
333-258539
ShelfEffective
 2021-08-062023-06-225
333-239698
IPOFinal prospectus
 2020-07-062020-07-304

Filings

17
FiledFilingRegistrationAccession
2026-04-13EFFECTDeclared effective 333-2948839999999995-26-001176
2026-04-13EFFECTDeclared effective 333-2948819999999995-26-001175
2026-04-03S-3Shelf registered 333-2948830001193125-26-142199
2026-04-03S-3Shelf registered 333-2948810001193125-26-142151
2025-02-10EFFECTDeclared effective 333-2836789999999995-25-000372
2024-02-15RWWithdrawn 333-2698080001193125-24-037577
2023-06-22424B5Shelf takedown 333-2585390001193125-23-172686
2023-06-21424B5Shelf takedown 333-2585390001193125-23-171320
2023-02-15S-3Shelf registered 333-2698080001193125-23-040261
2022-07-27424B5Shelf takedown 333-2585390001193125-22-203540
2022-02-28EFFECTDeclared effective 333-2585399999999995-22-000522
2021-08-06S-3ASRShelf registered 333-2585390001193125-21-238719
2020-07-30424B4Final prospectus 333-2396980001193125-20-204368
2020-07-29EFFECTDeclared effective 333-2396989999999995-20-001953
2020-07-23S-1/AAmendment 333-2396980001193125-20-197425
2020-07-06S-1Registration filed 333-2396980001193125-20-187665
2020-06-03DRSDraft made public 377-031990000950123-20-005825

All filings of this company · CSV